Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome

K Kuhn, HM Lederman… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Ataxia telangiectasia (AT) is a life-limiting autosomal recessive disease
characterized by cerebellar degeneration, ocular telangiectasias, and sinopulmonary …
被引用次数：3 相关文章

Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome.

K Kuhn, HM Lederman… - Expert Opinion on …, 2023 - europepmc.org
Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome

K Kuhn, HM Lederman… - Expert Opinion on …, 2023 - pure.johnshopkins.edu
Introduction: Ataxia telangiectasia (AT) is a life-limiting autosomal recessive disease
characterized by cerebellar degeneration, ocular telangiectasias, and sinopulmonary …

Ataxia-telangiectasia clinical trial landscape and the obstacles to overcome

K Kuhn, HM Lederman… - Expert opinion on … - pubmed.ncbi.nlm.nih.gov
Introduction Ataxia telangiectasia (AT) is a life-limiting autosomal recessive disease
characterized by cerebellar degeneration, ocular telangiectasias, and sinopulmonary …